<DOC>
	<DOCNO>NCT01965132</DOCNO>
	<brief_summary>We plan establish nationwide Biologics Registry ( form inception cohort ) study safety profile rheumatoid arthritis , ankylose spondylitis psoriatic arthritis patient receive biologic agents.As registry observe `` real world '' use anti-rheumatic treatment routine clinical practice , hypothesis prove plan .</brief_summary>
	<brief_title>Korean College Rheumatology Biologics Registry</brief_title>
	<detailed_description>This registry multi-centre , prospective , observational program gather analyze data patient treat biologics Korea . In contrast control clinical trial , impose experimental intervention solely patient ' physician determine patient 's treatment . Thus , data capture reported registry reflect `` real world '' approach treatment biologics . There additional visit laboratory test do outside routine clinical practice . Selection biologic agent , dose treatment duration discretion investigator . Informed consent obtain patient prior collection data .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Spondylitis</mesh_term>
	<mesh_term>Spondylitis , Ankylosing</mesh_term>
	<mesh_term>Arthritis , Psoriatic</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<mesh_term>Abatacept</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<mesh_term>Infliximab</mesh_term>
	<mesh_term>Ustekinumab</mesh_term>
	<criteria>Patients diagnose RA , AS PsA RA deem rheumatologist require treatment biologic nonbiologic DMARDs AS PsA patient initiate , restart switch biologic agent Patients provide write consent participate registry ( data collection review ) . RA , AS , PsA patient already biologics upon screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Rheumatiod Arhthritis</keyword>
	<keyword>Ankylosing spondylitis</keyword>
	<keyword>Psoriatic arthritis</keyword>
	<keyword>Biologic agent</keyword>
	<keyword>Cohort study</keyword>
</DOC>